Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Argus Health
Baxter
Mallinckrodt
Healthtrust
Moodys
Farmers Insurance
Deloitte
Johnson and Johnson

Generated: July 22, 2018

DrugPatentWatch Database Preview

Ipodate sodium - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for ipodate sodium and what is the scope of ipodate sodium freedom to operate?

Ipodate sodium
is the generic ingredient in two branded drugs marketed by Bayer Hlthcare and Bracco, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for ipodate sodium.
Summary for ipodate sodium
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 1
Bulk Api Vendors: 36
DailyMed Link:ipodate sodium at DailyMed

US Patents and Regulatory Information for ipodate sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco ORAGRAFIN SODIUM ipodate sodium CAPSULE;ORAL 012967-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare BILIVIST ipodate sodium CAPSULE;ORAL 087768-001 Aug 11, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Merck
Chinese Patent Office
Deloitte
Healthtrust
Mallinckrodt
Moodys
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.